Navigation Links
Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics

NEW BRUNSWICK, N.J., Sept. 28 /PRNewswire-USNewswire/ -- James M. Golubieski, president of Foundation Venture Capital Group, LLC, announced today that the company has made a $500,000 commitment to CellXplore, Inc., a start-up company at the University of Medicine & Dentistry of New Jersey (UMDNJ) committed to breast cancer diagnostics.

Kiran Madura, Ph.D., chief scientific officer of CellXplore and professor in the Department of Biochemistry at UMDNJ-Robert Wood Johnson Medical School (RWJMS), founded the company.

CellXplore has identified several biomarkers that could help in the non- invasive diagnosis of breast cancer, using a biochemical analysis of blood samples to identify specific proteins found in those who have the disease. According to Dr. Madura, the eventual hope is that the strategy would not only be able to help diagnose breast and other cancers but might also be able to discriminate between different types and stages, which would be helpful in establishing targeted treatment plans for patients.

"While we are currently focusing on breast cancer biomarkers, in the future we will investigate whether blood sample biomarkers can also be identified for the early diagnosis of major, debilitating illnesses such as muscle wasting disease and neurodegenerative conditions including Alzheimer's and Parkinson's Disease," he explained.

George F. Heinrich, M.D., vice chair and CEO of Foundation Venture Capital Group, is enthusiastic about this new company and what the investment means for the University.

"Our investment in CellXplore reinforces our strong relationship with UMDNJ and our willingness to invest in companies that might not otherwise receive support at this early stage," said Dr. Heinrich. "Dr. Madura and his company are developing very promising technology that has great potential in the diagnosis of cancer and other devastating diseases."

Foundation Venture Capital Group was founded in 2006 to invest in commercially viable new start-up companies developing technology at the University of Medicine & Dentistry of New Jersey. CellXplore is its second investment within the past six months.

SOURCE Foundation Venture Capital Group, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: